Works by Mosolov, Sergey N.


Results: 11
    1
    2

    Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.

    Published in:
    2007
    By:
    • Patil, Sandeep T;
    • Zhang, Lu;
    • Martenyi, Ferenc;
    • Lowe, Stephen L;
    • Jackson, Kimberley A;
    • Andreev, Boris V;
    • Avedisova, Alla S;
    • Bardenstein, Leonid M;
    • Gurovich, Issak Y;
    • Morozova, Margarita A;
    • Mosolov, Sergey N;
    • Neznanov, Nikolai G;
    • Reznik, Alexander M;
    • Smulevich, Anatoly B;
    • Tochilov, Vladimir A;
    • Johnson, Bryan G;
    • Monn, James A;
    • Schoepp, Darryle D
    Publication type:
    Correction Notice
    3

    Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.

    Published in:
    Nature Medicine, 2007, v. 13, n. 9, p. 1102, doi. 10.1038/nm1632
    By:
    • Patil, Sandeep T.;
    • Lu Zhang;
    • Martenyi, Ferenc;
    • Lowe, Stephen L.;
    • Jackson, Kimberley A.;
    • Andreev, Boris V.;
    • Avedisova, Alla S.;
    • Bardenstein, Leonid M.;
    • Gurovich, Issak Y.;
    • Morozova, Margarita A.;
    • Mosolov, Sergey N.;
    • Neznanov, Nikolai G.;
    • Reznik, Alexander M.;
    • Smulevich, Anatoly B.;
    • Tochilov, Vladimir A.;
    • Johnson, Bryan G.;
    • Monn, James A.;
    • Schoepp, Darryle D.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    11